Cargando…
A conserved role for AMP-activated protein kinase in NGLY1 deficiency
Mutations in human N-glycanase 1 (NGLY1) cause the first known congenital disorder of deglycosylation (CDDG). Patients with this rare disease, which is also known as NGLY1 deficiency, exhibit global developmental delay and other phenotypes including neuropathy, movement disorder, and constipation. N...
Autores principales: | Han, Seung Yeop, Pandey, Ashutosh, Moore, Tereza, Galeone, Antonio, Duraine, Lita, Cowan, Tina M., Jafar-Nejad, Hamed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769621/ https://www.ncbi.nlm.nih.gov/pubmed/33315951 http://dx.doi.org/10.1371/journal.pgen.1009258 |
Ejemplares similares
-
NGLY1 Deficiency, a Congenital Disorder of Deglycosylation: From Disease Gene Function to Pathophysiology
por: Pandey, Ashutosh, et al.
Publicado: (2022) -
Gut barrier defects, intestinal immune hyperactivation and enhanced lipid catabolism drive lethality in NGLY1-deficient Drosophila
por: Pandey, Ashutosh, et al.
Publicado: (2023) -
GlcNAc-Asn is a biomarker for NGLY1 deficiency
por: Mueller, William F, et al.
Publicado: (2021) -
NGLY1 deficiency: estimated incidence, clinical features, and genotypic spectrum from the NGLY1 Registry
por: Stanclift, Caroline R., et al.
Publicado: (2022) -
JF1/B6F1 Ngly1(−/−) mouse as an isogenic animal model of NGLY1 deficiency
por: ASAHINA, Makoto, et al.
Publicado: (2021)